Discover 936 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
for
Sickle Cell Disease
Location: Portland OR, Clovis CA, Los Angeles CA, Phoenix AZ,
Sponsor: Sanofi
Sex: All
Age: 10 - 65
Code: NCT06975865
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Morbidity and Mortality Among Dialysis Patients After Treatment for Depression
for
Depression, ESRD
Location: Portland OR
Sponsor: Portland VA Medical Center
Sex: All
Age: 18+
Code: NCT00442429
Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
Location: Portland OR, West Valley City UT, Los Angeles CA,
Sponsor: MacroGenics
Sex: All
Age: 18+
Code: NCT06242470
Phase 1, Recruiting
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
for
NSCLC
Location: Portland OR, Seattle WA, Stanford CA, Los Angeles CA,
Sponsor: Ellipses Pharma
Sex: All
Age: 18+
Code: NCT05443126
Phase 1, Phase 2, Recruiting
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
for
Aortic Aneurysm, Abdominal
Location: Portland OR, Stanford CA, La Jolla CA, Tulsa OK,
Sponsor: FCRE (Foundation for Cardiovascular Research and Education)
Sex: All
Age: 18+
Code: NCT04503395
Recruiting
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
for
Aortic Stenosis
Location: Portland OR, Spokane WA, Missoula MT, Sacramento CA,
Sponsor: Medtronic Cardiovascular
Sex: All
Age: 18 - 70+
Code: NCT06777368
Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Portland OR, West Vancouver, Kelowna, Miami FL,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Location: Portland OR, Silverdale WA, Sacramento CA, Mesa AZ,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07482176
Phase 3, Recruiting
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
for
Chronic Myelogenous Leukemia - Chronic Phase
Location: Salem OR, Tacoma WA, Seattle WA, Stockton CA,